These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 10614892)

  • 1. The use of a Bayesian forecasting model in the management of warfarin therapy after total hip arthroplasty.
    Motykie GD; Mokhtee D; Zebala LP; Caprini JA; Kudrna JC; Mungall DR
    J Arthroplasty; 1999 Dec; 14(8):988-93. PubMed ID: 10614892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of warfarin for venous thromboembolism prophylaxis following knee and hip arthroplasty: results of the Michigan Anticoagulation Quality Improvement Initiative (MAQI2).
    Barnes GD; Kaatz S; Golgotiu V; Gu X; Leidal A; Kobeissy A; Haymart B; Kline-Rogers E; Kozlowski J; Almany S; Leyden T; Froehlich JB
    J Thromb Thrombolysis; 2013 Jan; 35(1):10-4. PubMed ID: 22797905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience].
    Míka P; Behounek J; Skoták M; Nevsímal L
    Acta Chir Orthop Traumatol Cech; 2004; 71(4):237-44. PubMed ID: 15456102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of a nomogram and physician-adjusted dosage of warfarin for prophylaxis against deep-vein thrombosis after arthroplasty.
    Anderson DR; Wilson SJ; Blundell J; Petrie D; Leighton R; Stanish W; Alexander D; Robinson KS; Burton E; Gross M
    J Bone Joint Surg Am; 2002 Nov; 84(11):1992-7. PubMed ID: 12429760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Majority of Total Joint Arthroplasties Are Subtherapeutic on Warfarin at Time of Discharge: Another Reason to Avoid Warfarin as a Venous Thromboembolism Prophylaxis?
    Rondon AJ; Goswami K; Tan TL; Shohat N; Parvizi J
    J Arthroplasty; 2018 Sep; 33(9):2787-2791. PubMed ID: 29871833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recommendations for the post-operative management of an existing Warfarin therapy after lower limb joint arthroplasty.
    Roumeliotis L; Jenkins C; Budithi SC; Karlakki S
    Surgeon; 2019 Aug; 17(4):225-232. PubMed ID: 30195864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of oral anticoagulation therapy on deep vein thrombosis rates four weeks after total hip replacement.
    Caprini JA; Arcelus JI; Motykie G; Kudrna JC; Mokhtee D; Reyna JJ
    J Vasc Surg; 1999 Nov; 30(5):813-20. PubMed ID: 10550178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Warfarin for venous thromboembolism prophylaxis after elective hip or knee arthroplasty: exploring the evidence, guidelines, and challenges remaining.
    Dager WE
    Ann Pharmacother; 2012 Jan; 46(1):79-88. PubMed ID: 22202495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Warfarin prophylaxis in patients after total knee or hip arthroplasty--international normalized ratio patterns and venous thromboembolism.
    Nordstrom BL; Kachroo S; Fraeman KH; Nutescu EA; Schein JR; Fisher A; Bookhart BK
    Curr Med Res Opin; 2011 Oct; 27(10):1973-85. PubMed ID: 21919556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Home prophylactic warfarin anticoagulation program after hip and knee arthroplasty.
    Schuringa P; Yen D
    Can J Surg; 1999 Oct; 42(5):360-2. PubMed ID: 10526520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Warfarin responses in total joint and hip fracture patients.
    Messieh M; Huang Z; Johnson LJ; Jobin S
    J Arthroplasty; 1999 Sep; 14(6):724-9. PubMed ID: 10512445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Warfarin anticoagulation after total hip or total knee replacement: clinical and resource-utilization outcomes in a university-based antithrombosis clinic.
    Nutescu EA; Bautista A; Gao W; Galanter WL; Schumock GT; Mody SH; Bookhart BK; Lambert BL
    Am J Health Syst Pharm; 2013 Mar; 70(5):423-30. PubMed ID: 23413165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Warfarin for thromboprophylaxis following total joint arthroplasty: are patients safely anti-coagulated?
    Aynardi M; Brown PB; Post Z; Orozco F; Ong A
    J Arthroplasty; 2013 Sep; 28(8):1251-3. PubMed ID: 23608084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early Response to Warfarin Initiation and the Risk of Venous Thromboembolism After Total Joint Arthroplasty.
    Edelstein AI; Terzaghi C; Nudelman B; Qin C; Kwasny M; Manning DW
    J Am Acad Orthop Surg; 2018 Feb; 26(4):e90-e97. PubMed ID: 29351137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of a pharmacist-managed inpatient anticoagulation service for warfarin initiation and titration.
    Wong YM; Quek YN; Tay JC; Chadachan V; Lee HK
    J Clin Pharm Ther; 2011 Oct; 36(5):585-91. PubMed ID: 21070296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Search for predictors of nontherapeutic INR results with warfarin therapy.
    McGriff-Lee NJ; Csako G; Chen JT; Dang DK; Rosenfeld KG; Cannon RO; Macklin LR; Wesley RA;
    Ann Pharmacother; 2005 Dec; 39(12):1996-2002. PubMed ID: 16288081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cost effectiveness of anticoagulation management services for patients with atrial fibrillation and at high risk of stroke in the US.
    Sullivan PW; Arant TW; Ellis SL; Ulrich H
    Pharmacoeconomics; 2006; 24(10):1021-33. PubMed ID: 17002484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimization of inpatient warfarin therapy: impact of daily consultation by a pharmacist-managed anticoagulation service.
    Dager WE; Branch JM; King JH; White RH; Quan RS; Musallam NA; Albertson TE
    Ann Pharmacother; 2000 May; 34(5):567-72. PubMed ID: 10852081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Genotype-Guided Warfarin Dosing on Clinical Events and Anticoagulation Control Among Patients Undergoing Hip or Knee Arthroplasty: The GIFT Randomized Clinical Trial.
    Gage BF; Bass AR; Lin H; Woller SC; Stevens SM; Al-Hammadi N; Li J; Rodríguez T; Miller JP; McMillin GA; Pendleton RC; Jaffer AK; King CR; Whipple BD; Porche-Sorbet R; Napoli L; Merritt K; Thompson AM; Hyun G; Anderson JL; Hollomon W; Barrack RL; Nunley RM; Moskowitz G; Dávila-Román V; Eby CS
    JAMA; 2017 Sep; 318(12):1115-1124. PubMed ID: 28973620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pilot study of a novel patient self-management program for warfarin therapy using venipuncture-acquired international normalized ratio monitoring.
    Simmons BJ; Jenner KM; Delate T; Clark NP; Kurz D; Witt DM
    Pharmacotherapy; 2012 Dec; 32(12):1078-84. PubMed ID: 23112110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.